Friday 12 April 2019
Impact of Antithrombotic Regimen and Platelet Inhibition Extent on Leaflet Thrombosis Detected by Cardiac MDCT after Transcatheter Aortic Valve Replacement
Charline JIMENEZ
SLT is evidenced in a sizeable proportion of patients treated by TAVR and is mainly determined the lack of anticoagulant therapy. Conversely, no impact of platelet inhibition extent on SLT could be evidenced. Ongoing randomized prospective studies will provide important insights on the optimal antithrombotic strategy after TAVR.
Le SLT est fréquent chez les patients TAVR, principalement en raison de l'absence de traitement anticoagulant. L'inhibition des plaquettes n'a pas d'impact sur le SLT. Des études en cours détermineront la meilleure stratégie antithrombotique après TAVR.